Published in J Surg Res on August 27, 2008
The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury. Transplantation (2010) 1.62
The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection. World J Surg (2012) 0.81
The hepatoprotective effects of Hypericum perforatum L. on hepatic ischemia/reperfusion injury in rats. Cytotechnology (2013) 0.81
Hypoxia sensitization of hepatocytes to neutrophil elastase-mediated cell death depends on MAPKs and HIF-1α. Am J Physiol Gastrointest Liver Physiol (2012) 0.76
Combined effects of a neutrophil elastase inhibitor (sivelestat sodium) and a free radical scavenger (edaravone) on lipopolysaccharide-induced acute lung injury in rats. Inflamm Res (2012) 0.76
Neutrophil Elastase Inhibitor Following Liver Resection: A Matched Cohort Study. Hepat Mon (2015) 0.75
Preventive role of gallic acid on hepatic ischemia and reperfusion injury in rats. Cytotechnology (2014) 0.75
Interaction between Kupffer cells and platelets in the early period of hepatic ischemia-reperfusion injury--an in vivo study. J Surg Res (2012) 2.09
Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol (2003) 1.94
Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study. Radiology (2009) 1.88
Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting. Gastroenterology (2006) 1.74
Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer. JOP (2010) 1.59
Protective effect of heme oxygenase-1 on hepatic ischemia-reperfusion injury through inhibition of platelet adhesion to the sinusoids. J Gastroenterol Hepatol (2013) 1.45
C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes. Blood (2013) 1.45
Human platelets promote liver regeneration with Kupffer cells in SCID mice. J Surg Res (2012) 1.42
Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics (2006) 1.30
Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg (2007) 1.29
Infrequent occurrence of age-dependent changes in CpG island methylation as detected by restriction landmark genome scanning. Mech Ageing Dev (2002) 1.21
Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions. World J Gastroenterol (2009) 1.18
Developments for a growing Japanese patient population: facilitating new technologies for future health care. J Proteomics (2010) 1.15
Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin Cancer Res (2005) 1.15
Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol (2003) 1.13
Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness. Clin Cancer Res (2012) 1.13
Elovl6 promotes nonalcoholic steatohepatitis. Hepatology (2012) 1.13
Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics (2006) 1.11
Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.11
Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Int J Cancer (2009) 1.10
Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology (2008) 1.10
Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology (2007) 1.04
Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology (2004) 1.04
MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications. Eur J Cancer (2008) 1.03
Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol (2005) 1.01
The impact of liver metastasis on mortality in patients initially diagnosed with locally advanced or resectable pancreatic cancer. Int J Gastrointest Cancer (2003) 1.01
Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene (2004) 1.01
Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis (2008) 1.01
Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor. J Exp Med (2012) 1.00
Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome. Clin Cancer Res (2008) 1.00
Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin Cancer Res (2008) 1.00
Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics (2005) 0.99
Platelets promote liver regeneration in early period after hepatectomy in mice. World J Surg (2007) 0.99
Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clin Cancer Res (2007) 0.99
Proteomic signature of human cancer cells. Proteomics (2004) 0.99
Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor. J Surg Res (2010) 0.98
Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg (2011) 0.98
Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia. Transpl Int (2003) 0.97
Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer. Cancer Sci (2013) 0.97
Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Hepatology (2010) 0.97
Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice. Cancer Sci (2010) 0.97
Size control of calcium alginate beads containing living cells using micro-nozzle array. Biomaterials (2005) 0.96
Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol (2008) 0.96
Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma. Am J Surg (2011) 0.95
Well-differentiated endocrine carcinoma originating from the bile duct in association with a congenital choledochal cyst. Int Surg (2013) 0.95
Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res (2003) 0.95
Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann Surg (2008) 0.95
Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol (2005) 0.94
Cholangiocarcinoma arising from preexisting biliary hamartoma of liver--report of a case. Hepatogastroenterology (2003) 0.93
Dual assemblies of an activating immune receptor, MAIR-II, with ITAM-bearing adapters DAP12 and FcRgamma chain on peritoneal macrophages. J Immunol (2007) 0.93
Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma. J Proteomics (2013) 0.93
Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein. Oncogene (2005) 0.92
MDR1 gene polymorphism in Japanese patients with schizophrenia and mood disorders including depression. Biol Pharm Bull (2006) 0.92
Use of older controlled non-heart-beating donors for liver transplantation. Transplantation (2003) 0.92
MR imaging of reactive lymphoid hyperplasia of the liver. J Gastrointest Surg (2011) 0.92
Microfabricated airflow nozzle for microencapsulation of living cells into 150 micrometer microcapsules. Biomed Microdevices (2007) 0.92
Renal graft loss with plasma cell-rich acute rejection in cadaveric renal transplantation: a case report. Clin Transplant (2005) 0.92
NC-6300, an epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin. Cancer Sci (2013) 0.92
Gastric bronchogenic cyst histologically diagnosed after laparoscopic excision: report of a case. Int Surg (2013) 0.92
Tubular gel fabrication and cell encapsulation in laminar flow stream formed by microfabricated nozzle array. Lab Chip (2008) 0.91
Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. J Proteomics (2011) 0.91
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment. Cancer Sci (2009) 0.91
Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene (2002) 0.91
Effect of portocaval shunt on residual extreme small liver after extended hepatectomy in porcine. World J Surg (2006) 0.91
Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. J Proteome Res (2013) 0.91
Identification of natural antisense transcripts involved in human colorectal cancer development. Int J Oncol (2010) 0.91
Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J Hepatol (2010) 0.90
Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage. Cancer Sci (2009) 0.90
Preoperative 3D volumetric analysis for liver congestion applied in a patient with hilar cholangiocarcinoma. Langenbecks Arch Surg (2009) 0.90
Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. J Proteomics (2011) 0.90
A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan. EBioMedicine (2015) 0.89
Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics (2006) 0.88
Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol (2008) 0.87
Development- and activity-dependent regulation of SNAP-25 phosphorylation in rat brain. Neurosci Lett (2006) 0.87
Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells (2014) 0.87